Published: 24 July 2026
Revised: 24 August 2026
Medicines
Summary of Underpinning Analysis
| Date | Notice Number | Type |
|---|---|---|
| 20 August 2026 | 2026-sl4597 | Consent to the Distribution of New Medicines (Section 20) |
| 20 August 2026 | 2026-sl4596 | Consent to the Distribution of New Medicines (Section 24(5)) |
| 19 August 2026 | 2026-sl4686 | Classification of Medicines |
| 13 August 2026 | 2026-sl4481 | Consent to the Distribution of New Medicines (Section 24(5)) |
| 13 August 2026 | 2026-sl4480 | Consent to the Distribution of New Medicines (Section 20) |
| 6 August 2026 | 2026-sl4314 | Consent to the Distribution of New Medicines (Section 24(5)) |
| 3 August 2026 | 2026-sl4278 | Classification of Medicines |
| 30 July 2026 | 2026-sl4145 | Consent to the Distribution of New Medicines (Section 24(5)) |
| 30 July 2026 | 2026-sl4144 | Consent to the Distribution of a New Related Product |
| 23 July 2026 | 2026-sl3954 | Consent to the Distribution of New Medicines (Section 24(5)) |
| 23 July 2026 | 2026-sl3953 | Consent to the Distribution of New Medicines (Section 20) |
| 15 July 2025 | 2026-sl3859 | Provisional Consent to the Distribution of New Medicines |
